help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riggs, B. L.
Right arrow Articles by Melton, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riggs, B. L.
Right arrow Articles by Melton, L. J., III
Endocrine Reviews 23 (3): 279-302
Copyright © 2002 by The Endocrine Society

Sex Steroids and the Construction and Conservation of the Adult Skeleton

B. Lawrence Riggs, Sundeep Khosla and L. Joseph Melton, III

Division of Endocrinology and Metabolism (B.L.R., S.K., L.J.M.), Department of Internal Medicine, and Section of Clinical Epidemiology (L.J.M.), Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, Minnesota 55905

Correspondence: Address all correspondence and requests for reprints to: B. Lawrence Riggs, M.D., Mayo Clinic and Mayo Foundation, 200 First Street SW, North 6 Plummer, Rochester, Minnesota 55905.

Here we review and extend a new unitary model for the pathophysiology of involutional osteoporosis that identifies estrogen (E) as the key hormone for maintaining bone mass and E deficiency as the major cause of age-related bone loss in both sexes. Also, both E and testosterone (T) are key regulators of skeletal growth and maturation, and E, together with GH and IGF-I, initiate a 3- to 4-yr pubertal growth spurt that doubles skeletal mass. Although E is required for the attainment of maximal peak bone mass in both sexes, the additional action of T on stimulating periosteal apposition accounts for the larger size and thicker cortices of the adult male skeleton. Aging women undergo two phases of bone loss, whereas aging men undergo only one. In women, the menopause initiates an accelerated phase of predominantly cancellous bone loss that declines rapidly over 4–8 yr to become asymptotic with a subsequent slow phase that continues indefinitely. The accelerated phase results from the loss of the direct restraining effects of E on bone turnover, an action mediated by E receptors in both osteoblasts and osteoclasts. In the ensuing slow phase, the rate of cancellous bone loss is reduced, but the rate of cortical bone loss is unchanged or increased. This phase is mediated largely by secondary hyperparathyroidism that results from the loss of E actions on extraskeletal calcium metabolism. The resultant external calcium losses increase the level of dietary calcium intake that is required to maintain bone balance. Impaired osteoblast function due to E deficiency, aging, or both also contributes to the slow phase of bone loss. Although both serum bioavailable (Bio) E and Bio T decline in aging men, Bio E is the major predictor of their bone loss. Thus, both sex steroids are important for developing peak bone mass, but E deficiency is the major determinant of age-related bone loss in both sexes.




This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
G. N. Farhat, E. Taioli, J. A. Cauley, J. M. Zmuda, E. Orwoll, D. C. Bauer, T. J. Wilt, A. R. Hoffman, T. M. Beer, J. M. Shikany, et al.
The Association of Bone Mineral Density with Prostate Cancer Risk in the Osteoporotic Fractures in Men (MrOS) Study
Cancer Epidemiol. Biomarkers Prev., January 1, 2009; 18(1): 148 - 154.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
F. Callewaert, K. Venken, J. Ophoff, K. De Gendt, A. Torcasio, G. H. van Lenthe, H. Van Oosterwyck, S. Boonen, R. Bouillon, G. Verhoeven, et al.
Differential regulation of bone and body composition in male mice with combined inactivation of androgen and estrogen receptor-{alpha}
FASEB J, January 1, 2009; 23(1): 232 - 240.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
J. A. Hyder, M. A. Allison, N. Wong, A. Papa, T. F. Lang, C. Sirlin, S. M. Gapstur, P. Ouyang, J. J. Carr, and M. H. Criqui
Association of Coronary Artery and Aortic Calcium With Lumbar Bone Density: The MESA Abdominal Aortic Calcium Study
Am. J. Epidemiol., December 8, 2008; (2008) kwn303v1.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. M. Jankowski, W. S. Gozansky, J. M. Kittelson, R. E. Van Pelt, R. S. Schwartz, and W. M. Kohrt
Increases in Bone Mineral Density in Response to Oral Dehydroepiandrosterone Replacement in Older Adults Appear to Be Mediated by Serum Estrogens
J. Clin. Endocrinol. Metab., December 1, 2008; 93(12): 4767 - 4773.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
O. Khalid, S. K. Baniwal, D. J. Purcell, N. Leclerc, Y. Gabet, M. R. Stallcup, G. A. Coetzee, and B. Frenkel
Modulation of Runx2 Activity by Estrogen Receptor-{alpha}: Implications for Osteoporosis and Breast Cancer
Endocrinology, December 1, 2008; 149(12): 5984 - 5995.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. E. McGee-Lawrence, H. V. Carey, and S. W. Donahue
Mammalian hibernation as a model of disuse osteoporosis: the effects of physical inactivity on bone metabolism, structure, and strength
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1999 - R2014.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
P. M. Camacho, A. S. Dayal, J. L. Diaz, F. A. Nabhan, M. Agarwal, J. G. Norton, P. A. Robinson, and K. S. Albain
Prevalence of Secondary Causes of Bone Loss Among Breast Cancer Patients With Osteopenia and Osteoporosis
J. Clin. Oncol., November 20, 2008; 26(33): 5380 - 5385.
[Abstract] [Full Text] [PDF]

Home page
 Social Studies of ScienceHome page
A. Fausto-Sterling
The Bare Bones of Race
Social Studies of Science, October 1, 2008; 38(5): 657 - 694.
[Abstract] [PDF]

Home page
 Drug Metab. Dispos.Home page
C. Prakash, K. A. Johnson, C. M. Schroeder, and M. J. Potchoiba
Metabolism, Distribution, and Excretion of a Next Generation Selective Estrogen Receptor Modulator, Lasofoxifene, in Rats and Monkeys
Drug Metab. Dispos., September 1, 2008; 36(9): 1753 - 1769.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
A. Giustina, G. Mazziotti, and E. Canalis
Growth Hormone, Insulin-Like Growth Factors, and the Skeleton
Endocr. Rev., August 1, 2008; 29(5): 535 - 559.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Misra, D. K. Katzman, J. Cord, S. J. Manning, N. Mendes, D. B. Herzog, K. K. Miller, and A. Klibanski
Bone Metabolism in Adolescent Boys with Anorexia Nervosa
J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3029 - 3036.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
C. Prakash, K. A. Johnson, and M. J. Gardner
Disposition of Lasofoxifene, a Next-Generation Selective Estrogen Receptor Modulator, in Healthy Male Subjects
Drug Metab. Dispos., July 1, 2008; 36(7): 1218 - 1226.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Chevalley, J.-P. Bonjour, S. Ferrari, and R. Rizzoli
Influence of Age at Menarche on Forearm Bone Microstructure in Healthy Young Women
J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2594 - 2601.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. R. Hawse, M. Subramaniam, D. G. Monroe, A. H. Hemmingsen, J. N. Ingle, S. Khosla, M. J. Oursler, and T. C. Spelsberg
Estrogen Receptor {beta} Isoform-Specific Induction of Transforming Growth Factor {beta}-Inducible Early Gene-1 in Human Osteoblast Cells: An Essential Role for the Activation Function 1 Domain
Mol. Endocrinol., July 1, 2008; 22(7): 1579 - 1595.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. G. Bone, M. A. Bolognese, C. K. Yuen, D. L. Kendler, H. Wang, Y. Liu, and J. San Martin
Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women
J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2149 - 2157.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
K. Christo, R. Prabhakaran, B. Lamparello, J. Cord, K. K. Miller, M. A. Goldstein, N. Gupta, D. B. Herzog, A. Klibanski, and M. Misra
Bone Metabolism in Adolescent Athletes With Amenorrhea, Athletes With Eumenorrhea, and Control Subjects
Pediatrics, June 1, 2008; 121(6): 1127 - 1136.
[Abstract] [Full Text] [PDF]

Home page
 Journal of the American Dental AssociationHome page
B. J. Edwards and C. A. Migliorati
Osteoporosis and Its Implications for Dental Patients
J Am Dent Assoc, May 1, 2008; 139(5): 545 - 552.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. S. Lee, A. Z. LaCroix, L. Wu, J. A. Cauley, R. D. Jackson, C. Kooperberg, M. S. Leboff, J. Robbins, C. E. Lewis, D. C. Bauer, et al.
Associations of Serum Sex Hormone-Binding Globulin and Sex Hormone Concentrations with Hip Fracture Risk in Postmenopausal Women
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1796 - 1803.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. M. Ott
Reproductive Hormones and Skeletal Health in Young Women
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1175 - 1177.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Misra, R. Prabhakaran, K. K. Miller, M. A. Goldstein, D. Mickley, L. Clauss, P. Lockhart, J. Cord, D. B. Herzog, D. K. Katzman, et al.
Prognostic Indicators of Changes in Bone Density Measures in Adolescent Girls with Anorexia Nervosa-II
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1292 - 1297.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. H. Windahl, M. K. Lagerquist, N. Andersson, C. Jochems, A. Kallkopf, C. Hakansson, J. Inzunza, J.-A. Gustafsson, P. T. van der Saag, H. Carlsten, et al.
Identification of Target Cells for the Genomic Effects of Estrogens in Bone
Endocrinology, December 1, 2007; 148(12): 5688 - 5695.
[Abstract] [Full Text] [PDF]

Home page
 J Oncol PractHome page
T. Bao and N. E. Davidson
How We Maintain Bone Health in Early-Stage Breast Cancer Patients on Aromatase Inhibitors
J. Oncol. Pract, November 1, 2007; 3(6): 323 - 325.
[Full Text] [PDF]

Home page
 IBMS BoneKEyHome page
S. Khosla
Estrogen and the Death of Osteoclasts: A Fascinating Story
IBMS BoneKEy, October 1, 2007; 4(10): 267 - 272.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Swanson, M. Lorentzon, L. Vandenput, F. Labrie, A. Rane, J. Jakobsson, S. Chouinard, A. Belanger, and C. Ohlsson
Sex Steroid Levels and Cortical Bone Size in Young Men Are Associated with a Uridine Diphosphate Glucuronosyltransferase 2B7 Polymorphism (H268Y)
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3697 - 3704.
[Abstract] [Full Text] [PDF]

Home page
 J Am Acad Orthop SurgHome page
S. B. Goodman, W. Jiranek, E. Petrow, and A. W. Yasko
The Effects of Medications on Bone
J. Am. Acad. Ortho. Surg., August 1, 2007; 15(8): 450 - 460.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. J. Armstrong, M. Muzylak, A. Sunters, G. Zaman, L. K. Saxon, J. S. Price, and L. E. Lanyon
Wnt/beta-Catenin Signaling Is a Component of Osteoblastic Bone Cell Early Responses to Load-bearing and Requires Estrogen Receptor {alpha}
J. Biol. Chem., July 13, 2007; 282(28): 20715 - 20727.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
C. J Lees, J. R Kaplan, H. Chen, C. P Jerome, T. C Register, and A. A Franke
Bone mass and soy isoflavones in socially housed, premenopausal macaques
Am. J. Clinical Nutrition, July 1, 2007; 86(1): 245 - 250.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
J. Enriquez, A. E. Lemus, J. Chimal-Monroy, H. Arzate, G. A Garcia, B. Herrero, F. Larrea, and G. Perez-Palacios
The effects of synthetic 19-norprogestins on osteoblastic cell function are mediated by their non-phenolic reduced metabolites
J. Endocrinol., June 1, 2007; 193(3): 493 - 504.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. R. Williams
Hypogonadal Bone Loss: Sex Steroids or Gonadotropins?
Endocrinology, June 1, 2007; 148(6): 2610 - 2612.
[Full Text] [PDF]

Home page
 Endocr. Rev.Home page
M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu
Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System
Endocr. Rev., June 1, 2007; 28(4): 387 - 439.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Gao, R. Tiwari-Pandey, R. Samadfam, Y. Yang, D. Miao, A. C. Karaplis, M. R. Sairam, and D. Goltzman
Altered Ovarian Function Affects Skeletal Homeostasis Independent of the Action of Follicle-Stimulating Hormone
Endocrinology, June 1, 2007; 148(6): 2613 - 2621.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
M. Q. Hassan, R. Tare, S. H. Lee, M. Mandeville, B. Weiner, M. Montecino, A. J. van Wijnen, J. L. Stein, G. S. Stein, and J. B. Lian
HOXA10 Controls Osteoblastogenesis by Directly Activating Bone Regulatory and Phenotypic Genes
Mol. Cell. Biol., May 1, 2007; 27(9): 3337 - 3352.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. H. D. Bassett, P. J. O'Shea, S. Sriskantharajah, B. Rabier, A. Boyde, P. G. T. Howell, R. E. Weiss, J.-P. Roux, L. Malaval, P. Clement-Lacroix, et al.
Thyroid Hormone Excess Rather Than Thyrotropin Deficiency Induces Osteoporosis in Hyperthyroidism
Mol. Endocrinol., May 1, 2007; 21(5): 1095 - 1107.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. S. Perrien, N. S. Akel, P. K. Edwards, A. A. Carver, M. S. Bendre, F. L. Swain, R. A. Skinner, W. R. Hogue, K. M. Nicks, T. M. Pierson, et al.
Inhibin A Is an Endocrine Stimulator of Bone Mass and Strength
Endocrinology, April 1, 2007; 148(4): 1654 - 1665.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
G. I. Perez, A. Jurisicova, L. Wise, T. Lipina, M. Kanisek, A. Bechard, Y. Takai, P. Hunt, J. Roder, M. Grynpas, et al.
Absence of the proapoptotic Bax protein extends fertility and alleviates age-related health complications in female mice
PNAS, March 20, 2007; 104(12): 5229 - 5234.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Brufsky, W. G. Harker, J. T. Beck, R. Carroll, E. Tan-Chiu, C. Seidler, J. Hohneker, L. Lacerna, S. Petrone, and E. A. Perez
Zoledronic Acid Inhibits Adjuvant Letrozole-Induced Bone Loss in Postmenopausal Women With Early Breast Cancer
J. Clin. Oncol., March 1, 2007; 25(7): 829 - 836.
[Abstract] [Full Text] [PDF]

Home page
 IBMS BoneKEyHome page
J.-P. Bonjour and T. Chevalley
Pubertal Timing, Peak Bone Mass and Fragility Fracture Risk
IBMS BoneKEy, February 1, 2007; 4(2): 30 - 48.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. A. Riancho, C. Valero, A. Naranjo, D. J. Morales, C. Sanudo, and M. T. Zarrabeitia
Identification of an Aromatase Haplotype That Is Associated with Gene Expression and Postmenopausal Osteoporosis
J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 660 - 665.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
M. T Zarrabeitia, J. L Hernandez, C. Valero, A. Zarrabeitia, J. A Amado, J. Gonzalez-Macias, and J. A Riancho
Adiposity, estradiol, and genetic variants of steroid-metabolizing enzymes as determinants of bone mineral density
Eur. J. Endocrinol., January 1, 2007; 156(1): 117 - 122.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
A. M. Pino, J. M. Rodriguez, S. Rios, P. Astudillo, L. Leiva, G. Seitz, M. Fernandez, and J P. Rodriguez
Aromatase activity of human mesenchymal stem cells is stimulated by early differentiation, vitamin D and leptin
J. Endocrinol., December 1, 2006; 191(3): 715 - 725.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J.-R. Chen, R. L. Haley, M. Hidestrand, K. Shankar, X. Liu, C. K. Lumpkin, P. M. Simpson, T. M. Badger, and M. J. J. Ronis
Estradiol Protects against Ethanol-Induced Bone Loss by Inhibiting Up-Regulation of Receptor Activator of Nuclear Factor-{kappa}B Ligand in Osteoblasts
J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1182 - 1190.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
G. Jasienska, M. Kapiszewska, P. T. Ellison, M. Kalemba-Drozdz, I. Nenko, I. Thune, and A. Ziomkiewicz
CYP17 Genotypes Differ in Salivary 17-{beta} Estradiol Levels: A Study Based on Hormonal Profiles from Entire Menstrual Cycles.
Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2131 - 2135.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Hirbe, E. A. Morgan, O. Uluckan, and K. Weilbaecher
Skeletal complications of breast cancer therapies.
Clin. Cancer Res., October 15, 2006; 12(20): 6309s - 6314s.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Bjornerem, B. Straume, P. Oian, and G. K. R. Berntsen
Seasonal Variation of Estradiol, Follicle Stimulating Hormone, and Dehydroepiandrosterone Sulfate in Women and Men
J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3798 - 3802.
[Abstract] [Full Text] [PDF]

Home page
 J. Dent. Res.Home page
U.H. Lerner
Bone Remodeling in Post-menopausal Osteoporosis.
J. Dent. Res., July 1, 2006; 85(7): 584 - 595.
[Abstract] [Full Text] [PDF]

Home page
 FAKE JDRHome page
U.H. Lerner
Bone Remodeling in Post-menopausal Osteoporosis
Journal of Dental Research, July 1, 2006; 85(7): 584 - 595.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
N. Rasheed, X. Wang, Q.-T. Niu, J. Yeh, and B. Li
Atm-deficient mice: an osteoporosis model with defective osteoblast differentiation and increased osteoclastogenesis
Hum. Mol. Genet., June 15, 2006; 15(12): 1938 - 1948.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Bhasin, G. R. Cunningham, F. J. Hayes, A. M. Matsumoto, P. J. Snyder, R. S. Swerdloff, and V. M. Montori
Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 1995 - 2010.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. R. Ebeling
Inhibin in bone--new tricks for an old dog.
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1669 - 1670.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. S. Perrien, S. J. Achenbach, S. E. Bledsoe, B. Walser, L. J. Suva, S. Khosla, and D. Gaddy
Bone Turnover across the Menopause Transition: Correlations with Inhibins and Follicle-Stimulating Hormone
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1848 - 1854.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
M. C M Bunck, A. W F T Toorians, P. Lips, and L. J G Gooren
The effects of the aromatase inhibitor anastrozole on bone metabolism and cardiovascular risk indices in ovariectomized, androgen-treated female-to-male transsexuals.
Eur. J. Endocrinol., April 1, 2006; 154(4): 569 - 575.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. R. Sowers, M. Jannausch, D. McConnell, R. Little, G. A. Greendale, J. S. Finkelstein, R. M. Neer, J. Johnston, and B. Ettinger
Hormone Predictors of Bone Mineral Density Changes during the Menopausal Transition
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1261 - 1267.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Misra, K. K. Miller, P. Tsai, K. Gallagher, A. Lin, N. Lee, D. B. Herzog, and A. Klibanski
Elevated Peptide YY Levels in Adolescent Girls with Anorexia Nervosa
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1027 - 1033.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
N. A. Sims, K. Brennan, J. Spaliviero, D. J. Handelsman, and M. J. Seibel
Perinatal testosterone surge is required for normal adult bone size but not for normal bone remodeling
Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E456 - E462.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Sports. Med.Home page
S L Liu and C M Lebrun
Effect of oral contraceptives and hormone replacement therapy on bone mineral density in premenopausal and perimenopausal women: a systematic review
Br. J. Sports Med., January 1, 2006; 40(1): 11 - 24.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
I. J. Kerber, R. J. Turner, V. M. Miller, T. B. Clarkson, S. M. Harman, E. A. Brinton, M. Cedars, R. Lobo, J. E. Manson, G. R. Merriam, et al.
Eu-estrogenemia
J Appl Physiol, December 1, 2005; 99(6): 2471 - 2472.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. R. Ryan, R. Shepherd, J. K. Leavey, Y. Gao, F. Grassi, F. J. Schnell, W.-P. Qian, G. J. Kersh, M. N. Weitzmann, and R. Pacifici
An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiency
PNAS, November 15, 2005; 102(46): 16735 - 16740.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
N. Andersson, U. Islander, E. Egecioglu, E. Lof, C. Swanson, S. Moverare-Skrtic, K. Sjogren, M. K Lindberg, H. Carlsten, and C. Ohlsson
Investigation of central versus peripheral effects of estradiol in ovariectomized mice
J. Endocrinol., November 1, 2005; 187(2): 303 - 309.
[Abstract] [Full Text] [PDF]

Home page
 J Am Acad Orthop SurgHome page
K. Templeton
Secondary Osteoporosis
J. Am. Acad. Ortho. Surg., November 1, 2005; 13(7): 475 - 486.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Ichikawa, D. L. Koller, M. Peacock, M. L. Johnson, D. Lai, S. L. Hui, C. C. Johnston, T. M. Foroud, and M. J. Econs
Polymorphisms in the Estrogen Receptor {beta} (ESR2) Gene Are Associated with Bone Mineral Density in Caucasian Men and Women
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5921 - 5927.
[Abstract] [Full Text] [PDF]

Home page